Heterogeneity in MASLD Pathophysiology

Posted: 2025-04-12 19:09:14 UTC

@The Lancet Diabetes & EndocrinologyTheLancetEndo

#OpenAccess

#CVD

#obesity

#T2D

#MASLD

#ASCVD

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Full Thread

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Status

In Progress

VerifiedPartially VerifiedFalse

Last Updated

2025-04-12 19:09:20 UTC

Verified By

Rollup News

The pathophysiology of MASLD is heterogeneous, influencing its progression, relationship with cardiometabolic diseases, and response to therapy.

Heterogeneity in MASLD pathophysiology

Influence on disease progression

Relationship with cardiometabolic diseases

Response to therapy

Heterogeneity in contributors to pathophysiology